Vimta Labs Ltd

Vimta Labs Ltd | Sector: Miscellaneous | ISIN: INE579C01029

₹ 318.15 (-5.45%) icon

24 Mar, 2023, 3:48:28 PM
Open
₹ 338.00
Prev. Close
₹ 336.50
Turnover(lac)
₹ 73.90
Day's High
₹ 338.00
Day's Low
₹ 315.00
52 Wk High
₹ 503.80
52 Wk Low
₹ 291.00
Book Value
₹ 121.43
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 704.03
P/E
15.05
EPS
21.21
Div. Yield
0.63

KEY RATIOS

sector: Miscellaneous

  • CMP

    as on 3/24/2023 3:48:28 PM

    ₹ 318.15 -18.35 -5.45
  • Open
  • ₹ 338
  • Prev. Close
  • ₹ 336.5
  • Turnover(Lac.)
  • ₹ 74
  • Day's High
  • ₹ 338
  • Day's Low
  • ₹ 315
  • 52 Week's High
  • ₹ 503.8
  • 52 Week's Low
  • ₹ 291
  • Book Value
  • ₹ 121.43
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 704.03
  • P/E
  • 15.05
  • EPS
  • 21.21
  • Divi. Yield
  • 0.63

Corporate Actions

13 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Jan , 2023

12:00 AM

17 Oct , 2022

12:00 AM

17 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Jul , 2022

12:00 AM

12 May , 2022

12:00 AM

AGM

Announcement date: 12 May , 2022

View Details

12 May , 2022

12:00 AM

Dividend

Dividend amount: 2
Announcement date: 12 May , 2022

View Details

02 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 May , 2022

12:00 AM

30 May , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
24 March , 2023 | 08:46 PM

PROMOTER - TOTAL37.25%

Indian: 37.25%

Foreign: 0%

NON-PROMOTER - TOTAL 62.75%

Institutions: 4.40%

Non-Institutions: 58.34%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Vimta Labs Ltd News and Update

Image not found
  • 14 hours ago |
  • 4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:02 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Vimta Labs Ltd

  • S P Vasireddi

  • Chairman (Non-Executive)
  • V Harriman

  • Director (Operation)
  • Harita Vasireddi

  • Managing Director
  • Y Prameela Rani

  • Non-Exec. & Independent Dir.
  • Sujani Vasireddi

  • Company Sec. & Compli. Officer
  • G Purnachandra Rao

  • Non-Exec. & Independent Dir.
  • Sanjay Dave

  • Non-Exec. & Independent Dir.
  • Satya Sreenivas Neerukonda

  • Executive Director
  • Yadagiri R Pendri

  • Non-Exec. & Independent Dir.

Summary

Vimta Labs Ltd was Incorporated in the year 1990. The Laboratory was established in 1984 and developed a wide range of resources and testing capabilities. The Company is engaged in Contract Research and Analytical Testing Services. The Streams of Research and Testing are Contract Research (Clinical and Pre-clinical),Clinical Reference Laboratory Services (Central Lab), Analytical Testing of water,food,drugs etc.,and Environmental Monitoring and Impact Assessment. The Company was awarded ISO 9002 Certification under ISO/IEC Guide-25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company begun to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.The Company is now expanding its operations by five times of its existing capacities at S P Biotech Park, Genome Valley, Turkapally Village, Shamirpet Mandal, Ranga Reddy Dist. The project is expected to commence from September... Read More


Reports by Vimta Labs Ltd


Reports by Vimta Labs Ltd